DEXCOM INC cotiza a 85.80 USD y tiene una capitalización bursátil de $32.4B. En los últimos 12 meses ha facturado $5.0B con un margen de flujo de caja libre del 23.1%. Cotiza a 23.0 veces su flujo de caja libre (P/FCF) y a un PER de 32.4. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose moni…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.70 | $0.56 | $0.68 |
| Estimado | $0.67 | $0.61 | $0.47 | $0.65 |
| Sorpresa | — | +14.8% | +19.1% | +4.6% |
| Métrica | DXCM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 60.1% | 57.0% | +3.1% |
| Operating Margin | 19.6% | -38.6% | +58.2% |
| Net Margin | 17.9% | -33.6% | +51.5% |
| FCF Margin | 23.1% | -13.9% | +37.0% |
| ROE | 30.5% | -40.4% | +70.9% |
| ROA | 13.2% | -32.0% | +45.2% |
| Current Ratio | 1.88 | 2.84 | -0.96 |
| Debt / Equity | — | 0.28 | — |